Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RPAIN inhibitors(RPA interacting protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H23ClIN3O4 |
InChIKeyQHNTZIUSUGGSNE-UHFFFAOYSA-N |
CAS Registry1644626-43-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | US | 01 Jan 2015 | |
Ovarian Cancer | Preclinical | US | 01 Jan 2015 |